7 Biggest Price Target Changes For Tuesday - Aprea Therapeutics (NASDAQ:APRE), Arcturus Therapeutics (NASDAQ:ARCT)

HC Wainwright & Co. lowered the price target for Arcturus Therapeutics Holdings Inc ARCT from $84 to $50. Arcturus Therapeutics shares fell 33.6% to $61.29 in pre-market trading.
RBC Capital cut Aprea Therapeutics Inc APRE price target from $40 to $10. Aprea Therapeutics shares rose 2.6% to $5.64 in pre-market trading.
Baird lowered Arcturus Therapeutics Holdings Inc ARCT price target from $79 to $69. Arcturus Therapeutics shares fell 33.6% to $61.29 in pre-market trading.
Raymond James raised Wells Fargo & Co WFC price target from $32 to $35. Wells Fargo shares rose 0.6% to $30.12 in pre-market trading.
Credit Suisse boosted the price target on Cognizant Technology Solutions Corp CTSH from $79 to $91. Cognizant Technology shares closed at $81.37 on Monday.
Goldman Sachs raised Snap Inc SNAP price target from $47 to $70. Snap shares rose 6% to $51.15 in pre-market trading.
Credit Suisse cut the price target on Lantheus Holdings Inc LNTH from $16 to $14. Lantheus shares rose 0.4% to close at $14.80 on Monday.